SecurityHRS / Harris Corp. (413875105)
IndustrySearch, Detection, Navigation, Guidance, Aeronautical, and Nautical Systems and Instruments
Common Shares Outstanding118,728,914 shares (as of 2018-03-30)
Total Insiders27
Total Directors14
Total Officers13

Stock Insider Trading (from SEC Form 4)

Harris Corp. insider trades are listed in the following table, followed by a table containing the full transaction history. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.

HRS / Harris Corp. insiders include Young Christopher D., LOPEZ MIGUEL A, DATTILO THOMAS A, ZOISS EDWARD J, GHAI RAHUL, RICKARD DAVID B, STOFFEL JAMES C, FOX SHELDON J, BAILEY SALLIE B, and HAY LEWIS III, KENNE LESLIE F, MIKUEN SCOTT T, DUFFY ROBERT L, KATEN KAREN L, ALBAUGH JAMES F, FRADIN ROGER, TOOKES HANSEL E II, SWIENTON GREGORY T, SCHWARTZ LEWIS A Brown William M, JOSHI VYOMESH, MEHNERT DANA A, GROWCOCK TERRY D, GATTLE WILLIAM H, D'ALESSANDRO CARL D, CHIARELLI PETER W, Taylor Todd A., .

Insider Roster

Insider Dir Off 10% Shares Owned
ZOISS EDWARD J President, Electronic Systems
X
GROWCOCK TERRY D Director
X
FRADIN ROGER Director
X
DATTILO THOMAS A Director
X
CHIARELLI PETER W Director
X
BAILEY SALLIE B Director
X
ALBAUGH JAMES F Director
X
STOFFEL JAMES C Director
X
KENNE LESLIE F Director
X
JOSHI VYOMESH Director
X
HAY LEWIS III Director
X
TOOKES HANSEL E II Director
X
SWIENTON GREGORY T Director
X
MIKUEN SCOTT T Sr VP-General Counsel & Secy
X 47,219
GHAI RAHUL Sr. VP & Chief Financial Off.
X 9,247
DUFFY ROBERT L SVP-Human Resources
X 19,999
Taylor Todd A. VP, Principal Accting. Officer
X 2,801
FOX SHELDON J SVP, Operations and IT
X 49,470
Young Christopher D. President, Communication Sys.
X 23,875
MEHNERT DANA A SVP, Chief Global Bus Dev Off
X 74,435
Brown William M Chairman, President, and CEO
X 178,610
GATTLE WILLIAM H President, Space and Intel Sys
X 4,565
RICKARD DAVID B Director
X
KATEN KAREN L Director
X
D'ALESSANDRO CARL D President, Critical Networks
X
LOPEZ MIGUEL A Sr. VP & Chief Financial Off.
X
SCHWARTZ LEWIS A VP, Principal Accting. Officer
X

Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b-5 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Form Insider Code 10b-5 Direct Share
Price
Shares
Changed
Remaining
Shares
Post Value
2018-06-01 4 FOX SHELDON J F D 152.69 -346 49,470
2018-06-01 4 Taylor Todd A. F D 152.69 -353 2,801
2018-06-01 4 DUFFY ROBERT L F D 152.69 -1,236 19,999
2018-06-01 4 GHAI RAHUL F D 152.69 -1,056 9,247
2018-06-01 4 MIKUEN SCOTT T F D 152.69 -174 47,219
2018-05-29 4 Young Christopher D. F D 150.86 -18,526 23,875
2018-05-06 4 GHAI RAHUL F D 149.84 -2,055 10,303
2018-05-06 4 Taylor Todd A. F D 149.84 -1,310 3,154
2018-05-03 4 BAILEY SALLIE B A D 492 492
2018-03-05 4 Young Christopher D. D D 154.26 -2,475 42,384
2018-03-05 4 Young Christopher D. M D 2,475 44,859
2018-03-02 4 MIKUEN SCOTT T S D 151.64 -8,000 47,346 7,179,602
2018-03-02 4 MIKUEN SCOTT T S D 150.88 -12,000 55,346 8,350,659
2018-03-02 4 MIKUEN SCOTT T M X D 46.53 20,000 67,346
2018-03-05 4 MEHNERT DANA A S D 154.31 -400 74,435 11,486,134
2018-03-05 4 MEHNERT DANA A S D 153.82 -28,508 74,835 11,511,189
2018-03-05 4 MEHNERT DANA A S D 152.98 -11,792 103,343 15,809,481
2018-03-05 4 MEHNERT DANA A S D 151.69 -10,500 115,135 17,464,896
2018-03-05 4 MEHNERT DANA A M X D 56.97 51,200 125,635
2018-02-15 4 FOX SHELDON J S X D 156.40 -4,100 49,624 7,761,115
2018-02-15 4 FOX SHELDON J S X D 155.65 -4,582 53,724 8,362,063
2018-02-10 4 TOOKES HANSEL E II M D 333 1,667
2018-02-10 4 DATTILO THOMAS A M D 333 667
2018-02-10 4 GROWCOCK TERRY D M D 333 1,688
2018-02-10 4 HAY LEWIS III M D 333 4,895
2018-02-10 4 JOSHI VYOMESH M D 333 667
2018-02-10 4 KENNE LESLIE F M D 333 667
2018-02-10 4 STOFFEL JAMES C M D 333 667
2018-02-10 4 SWIENTON GREGORY T M D 333 667
2018-02-10 4 CHIARELLI PETER W M D 333 667
2017-12-15 4 FOX SHELDON J F D 144.09 -869 58,289
2017-12-15 4 MIKUEN SCOTT T F D 144.09 -435 47,334
2017-09-12 4 MIKUEN SCOTT T S D 123.3614 -13,600 47,749 5,890,329
2017-09-12 4 MIKUEN SCOTT T M D 46.53 13,600 61,349
2017-09-08 4 MIKUEN SCOTT T S X D 121.7031 -4,387 47,749 5,811,148
2017-08-25 4 ZOISS EDWARD J F D 119.66 -710 2,684
2017-08-25 4 ZOISS EDWARD J A D 192 3,394
2017-08-25 4 ZOISS EDWARD J M D 1,500 3,202
2017-08-25 4 GATTLE WILLIAM H F D 119.66 -781 4,565
2017-08-25 4 GATTLE WILLIAM H A D 211 5,346
2017-08-25 4 GATTLE WILLIAM H M D 1,650 5,135
2017-08-25 4 MEHNERT DANA A F D 119.66 -3,898 74,394
2017-08-25 4 MEHNERT DANA A A D 858 78,292
2017-08-25 4 MEHNERT DANA A M D 6,700 77,434
2017-08-25 4 MIKUEN SCOTT T F D 119.66 -3,171 52,136
2017-08-25 4 MIKUEN SCOTT T A D 858 55,307
2017-08-25 4 MIKUEN SCOTT T M D 6,700 54,449
2017-08-25 4 FOX SHELDON J F D 119.66 -3,644 58,734
2017-08-25 4 FOX SHELDON J A D 986 62,378
2017-08-25 4 FOX SHELDON J M D 7,700 61,392
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)

Related Articles

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

NVRO: Nevro Corp Analysis and Research Report

2018-07-06 - Asif

Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...

Related News Stories

The 20 Stocks From Goldman Sachs' Buy List That You Should Actually Consider | InvestorPlace

2018-07-11 investorplace
But recently, the equity research team at Goldman compiled a list of stocks within the company’s coverage universe that have the most potential upside to their price targets. The list is long (about 40 stocks), and Goldman pegs all of them as having roughly 30% or more upside to their price target. (28-0)

Harris Wins IDIQ Contracts to Enhance Geospatial Databases

2018-07-11 zacks
Harris Corporation (HRS - Free Report) recently secured three multi-award IDIQ contracts with ceilings totaling $1.5 billion to provide geospatial data services to the National Geospatial-Intelligence Agency (“NGA”) for a period of up to 10 years. (6-0)

Top Analyst Upgrades and Downgrades: Allergan, Cheniere, Clean Energy, Facebook, Fiat Chrysler, Intel, NetApp and More

2018-07-05 247wallst
Stocks were looking for a very strong open on Thursday after the Independence Day holiday had U.S. markets closed on Wednesday. The prior trend of buying the dips has been less reliable during most of 2018 than in prior years. Many investors have been considering how they want their investments positioned ahead of the midterm elections and also for the longer term. (57-0)

Telecom Stock Roundup: VZ Reality Ad Launch, CBB's Merger Deal & More

2018-06-21 zacks
In the last five trading days, telecom stocks flattered to deceive as the initial upturn was replaced by a persistent downturn for the most part of the past week as President Trump renewed fears of a fresh trade war with China. The on-again off-again trade war between the United States and China took a new turn when Trump imposed a fresh salvo of tariffs worth $50 billion on Chinese imports last week. (43-0)

Harris Sensor Boosts Japan's Environment Monitoring Effort

2018-06-14 zacks
Harris Corporation (HRS - Free Report) has launched an advanced environmental monitoring sensor to support Mitsubishi Electric Corporation’s upcoming Greenhouse Gases Observing Satellite-2 (GOSAT-2) project, significantly boosting Japan’s efforts to monitor greenhouse gases from space. The sensor will collect high-spectral resolution data. The newly built TANSO-FTS-2 sensor will measure greenhouse gases in the atmosphere through daylight and darkness, collecting the high spectral resolution data in five bands. (39-0)